May 15, 2013 -- The U.S. Food and Drug Administration today approved Xofigo to treat men with symptomatic late-stage castration-resistant prostate cancer that has spread to bones but not to other organs.
http://www.drugs.com/newdrugs/fda-approves-xofigo-advanced-prostate-cancer-3790.html?
http://www.drugs.com/newdrugs/fda-approves-xofigo-advanced-prostate-cancer-3790.html?
No comments:
Post a Comment